Inhibrx Biosciences, Inc. (INBX)

NMS – Real Time Price. Currency in USD

108.65

-18.93 (-14.84%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

200K

Cost of goods sold

-2M

-1M

Gross Profit

-1M

-2M

609K

Operating expenses (excl. COGS)

-134M

-329M

-220M

-130M

Operating Income

-135M

-331M

-219M

-129M

Non-operating income, total

-5M

2.02B

-21M

-16M

Pretax income

-140M

1.69B

-240M

-145M

Equity in earnings

-2M

Taxes

-2K

-3K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-140M

1.69B

-241M

-145M

Inhibrx Biosciences, Inc. (INBX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Inhibrx Biosciences, Inc. (INBX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Inhibrx Biosciences, Inc. (INBX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Inhibrx Biosciences, Inc. (INBX)

Income Statement (Annual)

Income Statement (Annual)